Physician defends use of antipsychotics for dementia patients in nursing homes

Share this article:

In response to a recent report from the Office of the Inspector General, a prominent psychiatrist is defending the practice of prescribing antipsychotic medications for nursing home residents with dementia.

The OIG report stated that off-label use of these drugs is widespread and dangerous. In his CNN.com opinion piece, Daniel Carlat, M.D., contends that just because a medication is used off-label, doesn't mean that drug's use is ineffective or “erroneous” as the OIG report states. Rather, it means that a drug hasn't undergone the expensive FDA approval process for a given indication, he said.

Furthermore, Carlat says antipsychotics are used to treat agitation associated with dementia, a symptom for which there is no approved drugs. He says agitation can be dangerous for caregivers and for the resident, but that it is especially upsetting for family members. Agitation is often the result of psychosis, Carlat writes.

Carlat argues the OIG's claim that antipsychotics can be lethal for dementia patients is questionable. He says that when antipsychotics such as Risperdal, Seroquel and Zyprexa were studied separately against placebos, there was no significant difference in the mortality rates.

While more research is needed, Carlat writes the most humane treatments for dementia patients, at the end of their lives, include any measures that calm them, including antipsychotics.
Share this article:

More in News

'Minor' issues at the nursing home can cause disastrous care transitions, expert warns

'Minor' issues at the nursing home can cause ...

What may appear to be minor administrative problems in a nursing home - a fax machine locked away at night or no one designated to copy paperwork - can cause ...

Long-term care facilities approach 80% worker flu vaccination rate after handing power ...

Fourteen long-term care facilities in Pennsylvania dramatically increased their staff flu vaccination rate by having a regional pharmacy take over the process, according to a report issued Thursday by the Agency for Healthcare Quality and Research (AHQR).

RACs were 'most improved' healthcare auditors for getting back money in 2013, ...

Medicare Recovery Audit Contractors dramatically stepped up their overpayment recoveries last year, returning nearly $487 million more to the government than they did in 2012, according to a new report from a federal watchdog agency.